Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by Pseudomonas aeruginosa isolates of pus samples in vitro

References

• Wilson LA, Schlitzer RL, Ahearn DG. Pseudomonas corneal ulcers associated with soft contact-lens wear. Am J Ophthalmol. 1981;92:546–554.
   PubMed Web of Science ®Google Scholar
• Sadikot RT, Blackwell TS, Christman JW, et al. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005;171:1209–1223.
   PubMed Web of Science ®Google Scholar
• Courtney J, Bradley J, Mccaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42:525–532.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Raman G, Sulham K, et al. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2014;3:32.
   PubMed Web of Science ®Google Scholar
• Salman M, Ali A, Haque A. A novel multiplex PCR for detection of Pseudomonas aeruginosa: a major cause of wound infections. Pak J Med Sci. 2013;29:957.
   PubMed Web of Science ®Google Scholar
• Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887–892.
   PubMed Web of Science ®Google Scholar
• Yasuda H, Ajiki Y, Koga T, et al. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother. 1993;37:1749–1755.
   PubMed Web of Science ®Google Scholar
• Japoni A, Farshad S, Alborzi A. Pseudomonas aeruginosa: burn infection, treatment and antibacterial resistance. Iran Red Crescent Med J. 2009;3:244–253.
   Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193.
   PubMed Web of Science ®Google Scholar
• Rewatkar A, Wadher B. Staphylococcus aureus and Pseudomonas aeruginosa-biofilm formation methods. IOSR-JPBS. 2013;8:36–40.
   Google Scholar
• DeVos WM. Microbial biofilms and the human intestinal microbiome. NPJ Biofilms Microbiomes. 2015;1:15005.
   PubMed Web of Science ®Google Scholar
• Shirtliff M, Leid JG. The role of biofilms in device-related infections. Vol. 2. Springer-Verlag Berlin Heidelberg: Springer; 2009. p. 1–44.
   Google Scholar
• Balzer M, Witt N, Flemming HC, et al. Faecal indicator bacteria in river biofilms. Water Sci Technol. 2010;61:1105–1111.
   PubMed Web of Science ®Google Scholar
• Morgan-Sagastume F, Larsen P, Nielsen JL, et al. Characterization of the loosely attached fraction of activated sludge bacteria. Water Res. 2008;42:843–854.
   PubMed Web of Science ®Google Scholar
• Percival SL, Malic S, Cruz H, et al. Introduction to biofilms. In: Percival SL, editor. Biofilms and veterinary medicine. Springer, Berlin, Heidelberg: Springer Press; 2011. p. 41–68.
   Google Scholar
• Marcinkiewicz J, Strus M, Pasich E. Antibiotic resistance: a “dark side” of biofilm associated chronic infections. Pol Arch Med Wewn. 2013;123:309–313.
   PubMed Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Castanheira M, et al. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12). J Antimicrob Chemother. 2014;69:2713–2722.
   PubMed Web of Science ®Google Scholar
• Deacon J, Abdelghany SM, Quinn DJ, et al. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa. Microbiol Rev. 2002;15:194–222.
   Google Scholar
• Domingues MM, Inácio RG, Raimundo JM, et al. Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems. Biopolymers. 2012;98:338–344.
   PubMed Web of Science ®Google Scholar
• Velkov T, Roberts KD, Thompson PE, et al. Polymyxins: a new hope in combating Gram-negative superbugs? Future Med Chem. 2016;8:1017–1025.
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–168.
   PubMed Web of Science ®Google Scholar
• de la Fuente-Núñez C, Reffuveille F, Mansour SC, et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol. 2015;22:196–205.
   PubMedGoogle Scholar
• Reffuveille F, de la Fuente-Núñez C, Mansour S, et al. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother. 2014;58:5363–5371.
   PubMed Web of Science ®Google Scholar
• Ravishankar Rai V, Jamuna Bai A. Nanoparticles and their potential application as antimicrobials. Science against microbial pathogens,” communicating current research and technological advances. In: Méndez-Vilas A, editor. Science against microbial pathogens: communicating current research and technological advances. 2011, p. 197–209. FORMATEX 2011.
   Google Scholar
• Hussain JI, Kumar S, Hashmi AA, et al. Silver nanoparticles: preparation, characterization, and kinetics. AML. 2011;2:188–194.
   Google Scholar
• Slomberg DL, Lu Y, Broadnax AD, et al. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces. 2013;5:9322–9329.
   PubMed Web of Science ®Google Scholar
• Su HL, Chou CC, Hung DJ, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials. 2009;30:5979–5987.
   PubMed Web of Science ®Google Scholar
• Abbaszadegan A, Ghahramani Y, Gholami A, et al. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: a preliminary study. Journal of Nanomaterials. 2015;16:53.
   Google Scholar
• Khan Z, Al-Thabaiti SA, Obaid AY, et al. Preparation and characterization of silver nanoparticles by chemical reduction method. Colloids Surf B Biointerfaces. 2011;82:513–517.
   PubMed Web of Science ®Google Scholar
• Ramalingam B, Parandhaman T, Das SK. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of gram-negative bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Appl Mater Interfaces. 2016;8:4963–4976.
   PubMed Web of Science ®Google Scholar
• Raytekar NA, Choudhari MR, Das S. Antibiotic profiling of Pseudomonas aeruginosa isolates from pus sample of rural tertiary care hospital of Western Maharashtra, Loni, India. Int J Res Med Sci. 2017;5:3076–3081.
   Google Scholar
• Andhale J, Misra R, Gandham N, et al. Incidence of Pseudomonas aeruginosa with special reference to drug resistance and biofilm formation from clinical samples in tertiary care hospital. J Pharm Biomed Sci. 2016;6:387–391.
   Google Scholar
• Sharma S, Srivastava P. Resistance of antimicrobial in Pseudomonas aeruginosa. Intjcurrmicrobiolappsci. 2016;5:121–128.
   Google Scholar
• Abidi SH, Sherwani SK, Siddiqui TR, et al. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol. 2013;13:57.
   PubMed Web of Science ®Google Scholar
• Wan G, Ruan L, Yin Y, et al. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii. IJN. 2016;11:3789.
   Web of Science ®Google Scholar
• Mohanty S, Mishra S, Jena P, et al. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomed Nanotechnol Biol Med. 2012;8:916–924.
   PubMed Web of Science ®Google Scholar
• Markowska K, Grudniak AM, Wolska KI. Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim Pol. 2013;60:523–530.
   PubMed Web of Science ®Google Scholar
• Fayaz AM, Balaji K, Girilal M, et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2010;6:103–109.
   PubMed Web of Science ®Google Scholar